Study of Radiotherapy and Pembrolizumab in People With Adrenocortical Carcinoma
Clinical trial NCT06066333 · RECRUITING
Trial details
- NCT number
- NCT06066333
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-27
- Primary completion
- 2026-09-27
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.